Program Research | NVI Research
Adult Congenital Heart Disease
Control/Tracking Number: 05-A-1239-CRF
Date: 6/9/2005
Procedural and Late Outcomes of Percutaneous Foramen Ovale Closure in 1000 Patients: A Single-Center Experience



Control/Tracking Number: 05-A-1248-CRF
Date: 6/9/2005
Use of the Amplatzer® SO Device for Percutaneous Patent Foramen Ovale Closure: Tunnel Reduction Technique and Initial Outcomes



Control/Tracking Number: 05-A-1250-CRF
Date: 6/9/2005
Migrane Induction by Brain Micro-Embolization During Contrast Transcranial Doppler Evaluation of Right-to-Left Shunt



Control/Tracking Number: 05-A-1261-CRF
Date: 6/9/2005
Late Failure of Percutaneous PFO Closure: Mechanism of Failure and Treatment Options



Control/Tracking Number: 05-SS-A-20407-AHA
Date: 5/27/2005
Late Adverse Events After Amplatzer® Closure of Patent Foramen Ovale in 350 Patients With High Risk Stratification for Recurrent Stroke



Control/Tracking Number: 05-SS-A-20713-AHA
Date: 5/27/2005
Amplatzer® Patent Foramen Ovale Closure Device Safety and Efficacy: 90-day Event Rates in 490 High Risk Stratified Patients
 
pfo treatment options   amplatzer pfo closure
home   |   patients   |   physicians   |   procedures   |   the team  |   facility / lab   |  faq   |   research   |  contact us
creative fire inc web design
© 2007 copyright. all rights reserved. sorensen cardiovascular group